Literature DB >> 21347594

Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III.

H Dirk Sostman1, Kathleen A Jablonski, Pamela K Woodard, Paul D Stein, David P Naidich, Thomas L Chenevert, John G Weg, Charles A Hales, Russell D Hull, Lawrence R Goodman, Victor F Tapson.   

Abstract

In a multi-center trial, gadolinium enhanced magnetic resonance angiography (MRA) for diagnosis of acute pulmonary embolism (PE) had a high rate of technically inadequate images. Accordingly, we evaluated the reasons for poor quality MRA of the pulmonary arteries in these patients. We performed a retrospective analysis of the data collected in the PIOPED III study. We assessed the relationship to the proportion of examinations deemed "uninterpretable" by central readers to the clinical centers, MR equipment platform and vendors, degree of vascular opacification in different orders of pulmonary arteries; type, frequency and severity of image artifacts; patient co-morbidities, symptoms and signs; and reader characteristics. Centers, MR equipment vendor and platform, degree of vascular opacification, and motion artifacts influenced the likelihood of central reader determinations that images were "uninterpretable". Neither the reader nor patient characteristics (age, body mass index, respiratory rate, heart rate) correlated with the likelihood of determining examinations "uninterpretable". Vascular opacification and motion artifact are the principal factors influencing MRA interpretability. Some centers obtain better images more consistently, but the reasons for differences between centers are unclear.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347594      PMCID: PMC3196681          DOI: 10.1007/s10554-011-9820-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  14 in total

1.  Small pulmonary emboli: what do we know?

Authors:  Lawrence R Goodman
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

2.  Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary embolism and contraindications to administration of iodinated contrast material.

Authors:  Hale Ersoy; Samuel Z Goldhaber; Tianxi Cai; Tuan Luu; Joshua Rosebrook; Robert Mulkern; Frank Rybicki
Journal:  AJR Am J Roentgenol       Date:  2007-05       Impact factor: 3.959

3.  Computed tomography pulmonary angiography: an assessment of the radiology report.

Authors:  Hani H Abujudeh; Rathachai Kaewlai; Khashayar Farsad; Esther Orr; Matthew Gilman; Jo-Anne O Shepard
Journal:  Acad Radiol       Date:  2009-08-18       Impact factor: 3.173

4.  Multidetector computed tomography for acute pulmonary embolism.

Authors:  Paul D Stein; Sarah E Fowler; Lawrence R Goodman; Alexander Gottschalk; Charles A Hales; Russell D Hull; Kenneth V Leeper; John Popovich; Deborah A Quinn; Thomas A Sos; H Dirk Sostman; Victor F Tapson; Thomas W Wakefield; John G Weg; Pamela K Woodard
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

5.  Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III).

Authors:  Paul D Stein; Thomas L Chenevert; Sarah E Fowler; Lawrence R Goodman; Alexander Gottschalk; Charles A Hales; Russell D Hull; Kathleen A Jablonski; Kenneth V Leeper; David P Naidich; Daniel J Sak; H Dirk Sostman; Victor F Tapson; John G Weg; Pamela K Woodard
Journal:  Ann Intern Med       Date:  2010-04-06       Impact factor: 25.391

6.  Prevalence of acute pulmonary embolism in central and subsegmental pulmonary arteries and relation to probability interpretation of ventilation/perfusion lung scans.

Authors:  P D Stein; J W Henry
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

7.  Performance of magnetic resonance angiography in suspected acute pulmonary embolism.

Authors:  Alain Blum; Abdelouahab Bellou; Francis Guillemin; Philippe Douek; Marie-Claude Laprévote-Heully; Denis Wahl
Journal:  Thromb Haemost       Date:  2005-03       Impact factor: 5.249

8.  Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine.

Authors:  Pamela K Woodard; Thomas L Chenevert; H Dirk Sostman; Kathleen A Jablonski; Paul D Stein; Lawrence R Goodman; Frank J Londy; Vamsidhar Narra; Charles A Hales; Russell D Hull; Victor F Tapson; John G Weg
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-20       Impact factor: 2.357

9.  Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA.

Authors:  Dariusch R Hadizadeh; Jürgen Gieseke; Stefan H Lohmaier; Kai Wilhelm; Jack Boschewitz; Frauke Verrel; Hans H Schild; Winfried A Willinek
Journal:  Radiology       Date:  2008-09-03       Impact factor: 11.105

10.  Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography.

Authors:  Mayil S Krishnam; Anderanik Tomasian; Vibhas Deshpande; Lien Tran; Gerhard Laub; J Paul Finn; Stefan G Ruehm
Journal:  Invest Radiol       Date:  2008-06       Impact factor: 6.016

View more
  5 in total

1.  MR Pulmonary angiography: assessment of PIOPED III data.

Authors:  Frank J Rybicki
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-24       Impact factor: 2.357

Review 2.  Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2013-04       Impact factor: 2.357

Review 3.  Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: Building a successful program.

Authors:  Scott K Nagle; Mark L Schiebler; Michael D Repplinger; Christopher J François; Karl K Vigen; Rajkumar Yarlagadda; Thomas M Grist; Scott B Reeder
Journal:  Eur J Radiol       Date:  2015-12-29       Impact factor: 3.528

Review 4.  Magnetic resonance angiography for the primary diagnosis of pulmonary embolism: A review from the international workshop for pulmonary functional imaging.

Authors:  Nanae Tsuchiya; Edwin Jr van Beek; Yoshiharu Ohno; Hiroto Hatabu; Hans-Ulrich Kauczor; Andrew Swift; Jens Vogel-Claussen; Jürgen Biederer; James Wild; Mark O Wielpütz; Mark L Schiebler
Journal:  World J Radiol       Date:  2018-06-28

Review 5.  SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.

Authors:  Tim Leiner; Jan Bogaert; Matthias G Friedrich; Raad Mohiaddin; Vivek Muthurangu; Saul Myerson; Andrew J Powell; Subha V Raman; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2020-11-09       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.